Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Hoeper

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|November 29, 2012
[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry]J Behr, M M Hoeper, M Kreuter, et al.
Rheumatology (Oxford, England)|September 17, 2008
Outcome measures in pulmonary arterial hypertension associated with systemic sclerosisO Kowal-Bielecka, M Delcroix, A Vonk-Noordegraaf, et al.
Herz|July 19, 2019
Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approachesS Rosenkranz, T Kramer, F Gerhardt, et al.
Pneumologie (Stuttgart, Germany)|May 21, 2010
[Diagnosis and treatment of pulmonary hypertension: European guidelines 2009]M M Hoeper, H A Ghofrani, M Gorenflo, et al.
Transplantation|August 19, 2000
Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppressionF Hoffmeyer, M M Hoeper, E Spiekerkötter, et al.
Postgraduate Medical Journal|April 7, 2005
Acute liver failure: a message found under the skinM Meier, A Woywodt, M M Hoeper, et al.
The European Respiratory Journal|May 17, 2007
Results of European post-marketing surveillance of bosentan in pulmonary hypertensionM Humbert, E S Segal, D G Kiely, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertensionM M Hoeper, R Maier, J Tongers, et al.
Respiratory Medicine|August 28, 1999
Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive diseaseM M Hoeper, C Eschenbruch, C Zink-Wohlfart, et al.
The European Respiratory Journal|September 3, 2011
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertensionN Nickel, H Golpon, M Greer, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|November 29, 2012
[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry]J Behr, M M Hoeper, M Kreuter, et al.
Rheumatology (Oxford, England)|September 17, 2008
Outcome measures in pulmonary arterial hypertension associated with systemic sclerosisO Kowal-Bielecka, M Delcroix, A Vonk-Noordegraaf, et al.
Herz|July 19, 2019
Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approachesS Rosenkranz, T Kramer, F Gerhardt, et al.
Pneumologie (Stuttgart, Germany)|May 21, 2010
[Diagnosis and treatment of pulmonary hypertension: European guidelines 2009]M M Hoeper, H A Ghofrani, M Gorenflo, et al.
Transplantation|August 19, 2000
Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppressionF Hoffmeyer, M M Hoeper, E Spiekerkötter, et al.
Postgraduate Medical Journal|April 7, 2005
Acute liver failure: a message found under the skinM Meier, A Woywodt, M M Hoeper, et al.
The European Respiratory Journal|May 17, 2007
Results of European post-marketing surveillance of bosentan in pulmonary hypertensionM Humbert, E S Segal, D G Kiely, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertensionM M Hoeper, R Maier, J Tongers, et al.
Respiratory Medicine|August 28, 1999
Effects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive diseaseM M Hoeper, C Eschenbruch, C Zink-Wohlfart, et al.
The European Respiratory Journal|September 3, 2011
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertensionN Nickel, H Golpon, M Greer, et al.
Pageof 10